As of the first of January 2020, the Spanish National Healthcare System began to finance varenicline and bupropion drugs to help the smoking population quit this harmful habit. These drugs, marketed as Champix (varenicline) and Zyntabac (bupropion) experienced thereafter a sharp increase in popularity reflected in the units sold in January 2020 relative to the same period in 2019. As can be seen, the sales of these smoking cessation drugs in 2020 amounted to 18.7 thousand units, representing a 300 percent growth compared to the previous year.
Number of units of smoking cessation medication Champix (varenicline) and Zyntabac (bupropion) sold in Spain during January 2019 and January 2020
Characteristic
Number of units
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
elEconomista. (February 7, 2020). Number of units of smoking cessation medication Champix (varenicline) and Zyntabac (bupropion) sold in Spain during January 2019 and January 2020 [Graph]. In Statista. Retrieved September 01, 2024, from https://www.statista.com/statistics/1114011/champix-and-zyntabac-units-sold-in-spain/
elEconomista. "Number of units of smoking cessation medication Champix (varenicline) and Zyntabac (bupropion) sold in Spain during January 2019 and January 2020." Chart. February 7, 2020. Statista. Accessed September 01, 2024. https://www.statista.com/statistics/1114011/champix-and-zyntabac-units-sold-in-spain/
elEconomista. (2020). Number of units of smoking cessation medication Champix (varenicline) and Zyntabac (bupropion) sold in Spain during January 2019 and January 2020. Statista. Statista Inc.. Accessed: September 01, 2024. https://www.statista.com/statistics/1114011/champix-and-zyntabac-units-sold-in-spain/
elEconomista. "Number of Units of Smoking Cessation Medication Champix (Varenicline) and Zyntabac (Bupropion) Sold in Spain during January 2019 and January 2020." Statista, Statista Inc., 7 Feb 2020, https://www.statista.com/statistics/1114011/champix-and-zyntabac-units-sold-in-spain/
elEconomista, Number of units of smoking cessation medication Champix (varenicline) and Zyntabac (bupropion) sold in Spain during January 2019 and January 2020 Statista, https://www.statista.com/statistics/1114011/champix-and-zyntabac-units-sold-in-spain/ (last visited September 01, 2024)
Number of units of smoking cessation medication Champix (varenicline) and Zyntabac (bupropion) sold in Spain during January 2019 and January 2020 [Graph], elEconomista, February 7, 2020. [Online]. Available: https://www.statista.com/statistics/1114011/champix-and-zyntabac-units-sold-in-spain/